Home › Funds › Royce & Associates › AVNS
Royce & Associates position in AVNS
AVANOS MED INC
Latest position (Q2 2026)60.70K sh
Reported value held$1.51M
Portfolio Weight0.01%
First reportedQ3 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 32.22K | $372.48K | New |
| Q4 2025 | 60.70K | $681.70K | Add |
| Q1 2026 | 513.70K | $7.20M | Add |
| Q2 2026 | 60.70K | $1.51M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVNS
- BlackRock Inc 7.47M sh · $185.82M · Q2 2026
- Vanguard Group 3.53M sh · $39.61M · Q4 2025
- Millennium Management 1.52M sh · $37.93M · Q2 2026
- Geode Capital Management 1.18M sh · $29.39M · Q2 2026
- JPMorgan Chase & Co 1.10M sh · $27.42M · Q2 2026
- Charles Schwab Investment Management 946.34K sh · $23.55M · Q2 2026
- Fidelity International (FIL) 815.00K sh · $20.28M · Q2 2026
- Goldman Sachs Group 765.42K sh · $19.04M · Q2 2026
- Balyasny Asset Management 739.83K sh · $18.41M · Q2 2026
- Northern Trust Corp 523.07K sh · $13.01M · Q2 2026
- Morgan Stanley 472.64K sh · $11.76M · Q2 2026
- Fidelity Management & Research (FMR) 377.49K sh · $9.39M · Q2 2026